Northwestern Mutual Wealth Management CO Biogen Inc. Transaction History

Northwestern Mutual Wealth Management CO

$118 Billion
Q4 2024

A detailed history of Northwestern Mutual Wealth Management CO transactions in Biogen Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 5,355 shares of BIIB stock, worth $749,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,355

Previous 6,669 19.7%

Holding current value

$749,057

Previous $1.29 Million 36.69%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$146.47 - $191.55 $192,461 - $251,696	-1,314 Reduced 19.7%	5,355 $818,000
Q3 2024 Nov 12, 2024	SELL	$189.07 - $236.8 $121,004 - $151,552	-640 Reduced 8.76%	6,669 $1.29 Million
Q2 2024 Aug 15, 2024	BUY	$190.52 - $236.72 $103,452 - $128,538	543 Added 8.03%	7,309 $1.69 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $116,186 - $146,705	-548 Reduced 7.49%	6,766 $1.46 Million
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $29,827 - $35,903	134 Added 1.87%	7,314 $1.89 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $486,842 - $549,480	-1,922 Reduced 21.12%	7,180 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $653,168 - $754,756	2,373 Added 35.27%	9,102 $2.59 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $68,758 - $78,347	268 Added 4.15%	6,729 $1.87 Million
Q4 2022 Feb 21, 2023	BUY	$252.44 - $306.72 $2,776 - $3,373	11 Added 0.17%	6,461 $1.79 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $13,822 - $19,060	71 Added 1.11%	6,450 $1.72 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $96,770 - $115,078	516 Added 8.8%	6,379 $1.3 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $215,278 - $271,239	1,111 Added 23.38%	5,863 $1.23 Million
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $121,140 - $155,683	-541 Reduced 10.22%	4,752 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $10,470 - $13,654	-37 Reduced 0.69%	5,293 $1.5 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $2.53 Million - $4.05 Million	-9,774 Reduced 64.71%	5,330 $1.85 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $614,906 - $720,398	2,531 Added 20.13%	15,104 $4.23 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $407,548 - $613,461	1,725 Added 15.9%	12,573 $3.08 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $928,548 - $1.07 Million	3,507 Added 47.77%	10,848 $3.08 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $647,943 - $858,087	2,505 Added 51.8%	7,341 $1.96 Million
Q1 2020 May 08, 2020	SELL	$268.85 - $341.04 $81,461 - $103,335	-303 Reduced 5.9%	4,836 $1.53 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $462,346 - $638,851	-2,101 Reduced 29.02%	5,139 $1.53 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $123,505 - $138,523	-568 Reduced 7.27%	7,240 $1.69 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $678,702 - $748,123	-3,095 Reduced 28.39%	7,808 $1.83 Million
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $4.43 Million - $6.92 Million	-20,428 Reduced 65.2%	10,903 $2.58 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $18,102 - $22,928	65 Added 0.21%	31,331 $9.43 Million
Q3 2018 Nov 01, 2018	BUY	$293.51 - $383.83 $205,457 - $268,681	700 Added 2.29%	31,266 $11 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $56,396 - $67,213	-219 Reduced 0.71%	30,566 $8.87 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $163,101 - $230,679	627 Added 2.08%	30,785 $8.43 Million
Q4 2017 Jan 31, 2018	BUY	$307.64 - $344.58 $2,768 - $3,101	9 Added 0.03%	30,158 $9.61 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $549,367 - $644,214	1,954 Added 6.93%	30,149 $9.44 Million
Q2 2017 Aug 10, 2017	BUY	N/A	28,195	28,195 $7.65 Million

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.

Account

Northwestern Mutual Wealth Management CO Biogen Inc. Transaction History